Spreadsheet: 911f5cbb-1f95-4a05-aa75-59a88db1bb52
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
F5IS | Test | F5IS | Coagulation Factor V Inhibitor Screen, Plasma | Coag Factor V Inhibitor Scrn, P | FACTV: [NAME] Assay F5_IS, IBETH: Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 3 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vials [NAME]: 3 mL in 3 plastic vials each containing 1 mL Collection Instructions: 1. Specimen must be drawn prior to factor replacement therapy. 2. Spin down, remove plasma, and spin plasma again. 3. Freeze specimens immediately at < or =-40 degrees C, if possible. 4. Send specimens in the same shipping container. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. If priority specimen, mark request form, give reason, and request a call-back. 3. Each coagulation assay requested should have its own vial. | 2 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | FACTOR V ACTIVITY ASSAY Adults: 75-165% Normal, full-term newborn infants may have borderline low or mildly decreased levels (> or =30-35%) which reach adult levels within 21 days postnatal.* Healthy premature infants (30-36 weeks gestation) may have borderline low or mildly decreased levels.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions.   FACTOR V INHIBITOR SCREEN Negative | Monday through Friday | 1 day | 3 days |  | Profile |  |  |  |  | Rochester
F5IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F5IS | Component | FACTV | Coagulation Factor V Activity Assay, Plasma | Coag Factor V Assay, P | [NAME] Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 1 | mL | See Coagulation Studies in Special Instructions.   Specimen Type: Platelet-poor plasma Collection Container/Tube: Light-blue top (citrate) Submission Container/Tube: Plastic vial [NAME]: 1 mL Collection Instructions: 1. Spin down, remove plasma, and spin plasma again.  2. Freeze specimen immediately at < or =-40 degrees C, if possible. Additional Information: 1. Double-centrifuged specimen is critical for accurate results as platelet contamination may cause spurious results. 2. Patient must not be receiving [NAME] or heparin therapy. 3. Each coagulation assay requested should have its own vial. 4. If priority specimen, mark request form, give reason, and request a call-back. 5. Coagulation testing is highly complex, often requiring the performance of multiple assays and correlation with clinical information. For that reason we suggest ordering Coagulation Consultations. | 0.5 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Adults: 70-165% Normal, full-term newborn infants may have borderline low or mildly decreased levels (> or =30% to 35%) which reach adult levels within 21 days postnatal. Healthy premature infants (30-36 weeks gestation) may have borderline low or mildly decreased levels.* *See Pediatric Hemostasis References in Coagulation Studies in Special Instructions. | Monday through Friday | 1 day | 2 days | 1 | 85220 |  |  | Yes | Yes
FACTV | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
FACTV | Result | FACTV | Coag Factor V Assay, P | Coag Factor V Assay, P | Numeric |  |  |  |  | % |  |  |  |  |  |  |  |  |  | 3193-0 | Coagulation factor V activity actual/Normal:RelTime:Pt:PPP:Qn:Coag
F5IS | Component | F5_IS | Factor V Inhibitor Screen | Factor V Inhib Scrn | Clot-Based Assay | Varies: Var |  |  |  | Varies |  | 2.0 mL | Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icterus	Mild OK; Gross reject Other	NA | Negative | Monday through Friday | 1 day | 3 days | 1 | 85335 |  |  | Yes | No
F5_IS | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
F5_IS | Result | 7808 | Factor V Inhib Scrn | Factor V Inhib Scrn | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
F5IS | [NAME] | IBETH | Bethesda Units | Bethesda Units | Clot-Based Assay | Light blue-top (citrate) tube: LgtBlu |  |  | 3 | mL |  |  | Specimens other than	Plasma Anticoagulants other than	Sodium citrate Hemolysis	Mild OK; Gross reject Thawing	Warm reject; Cold reject Lipemia	Mild OK; Gross reject Icteric	Mild OK; Gross reject | 0 unit | Monday through Friday | 2 days | 5 days | 1 | 85335 |  |  | No | No
IBETH | [NAME] | NACIT | [NAME] |  |  |  | Frozen | 14 days
IBETH | Result | 7288 | Bethesda Units | Bethesda Units | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13591-3 | Factor inhibitor [NAME]:ACnc:Pt:PPP:Qn:Coag